Cimaas logo Cimaas logo
  • About
    • Mission
    • CiMaas Team
    • Supervisory Board
    • Scientific Advisory Board
    • New therapeutic concepts
    • News archive
    • Careers
    • Collaborations
  • Technology
    • Technology
    • Adoptive NK cell therapy
    • Publications
  • Pipeline
  • Investors
  • General public
  • Contact
  • About
    • Mission
    • CiMaas Team
    • Supervisory Board
    • Scientific Advisory Board
    • New therapeutic concepts
    • News archive
    • Careers
    • Collaborations
  • Technology
    • Technology
    • Adoptive NK cell therapy
    • Publications
  • Pipeline
  • Investors
  • General public
  • Contact
Supervisory Board

SUPERVISORY BOARD

Latest news
  • CiMaas will resume operations November 2, 2024
  • CiMaas files for bankruptcy, aims for restart June 12, 2024
  • CiMaas and CYTEA BIO are pleased to announce their collaboration on Natural Killer cells May 19, 2024
  • CiMaas receives EMA qualification for NK cell product March 4, 2024
  • EU grants Seal of Excellence to CiMaas March 1, 2024
  • Disclaimer
  • Contact
visual design by scicomvisuals.
  • About
  • Technology
  • Pipeline
  • General public